Activation and blockade of mouse muscle nicotinic channels by antibodies directed against the binding site of the acetylcholine receptor
- PMID: 8730587
- PMCID: PMC1158865
- DOI: 10.1113/jphysiol.1996.sp021293
Activation and blockade of mouse muscle nicotinic channels by antibodies directed against the binding site of the acetylcholine receptor
Abstract
1. Using the patch-clamp technique, we have found that mouse muscle nicotinic acetylcholine receptor (nAChR) channels can be activated by low concentrations of a monoclonal antibody (MoAb), referred to as WF6, which is directed against the acetylcholine (ACh) binding site. Similar effects were seen using IgG or F(ab)2 fragments from the sera of patients with myasthenia gravis (MG), which contain polyclonal anti-nAChR antibodies. 2. The mean open times of MoAb and the slope conductance of single WF6-activated single channels were similar to those of ACh-activated channels under the same experimental conditions. 3. On outside-out patches, single channel activity was elicited by MoAb WF6 and MG F(ab)2 fragments, and was blocked by (+)-tubocurarine. We therefore concluded that MoAb WF6 and the MG F(ab)2 fragments activate the nAChR. 4. MoAb WF6 and MG F(ab)2 fragments blocked the current activated by pulsed application of 10(-4) M ACh to a significant extent. The block was partly reversible. The rate constants for the binding and dissociation of MoAb WF6 from the receptor were determined quantitatively.
Similar articles
-
Mechanism of block of nicotinic acetylcholine receptor channels by purified IgG from seropositive patients with myasthenia gravis.Neurology. 2000 Jan 25;54(2):474-9. doi: 10.1212/wnl.54.2.474. Neurology. 2000. PMID: 10668717
-
Open channel and competitive block of the embryonic form of the nicotinic receptor of mouse myotubes by (+)-tubocurarine.J Physiol. 1996 Aug 15;495 ( Pt 1)(Pt 1):83-95. doi: 10.1113/jphysiol.1996.sp021575. J Physiol. 1996. PMID: 8866353 Free PMC article.
-
Interactions of bupivacaine with ionic channels of the nicotinic receptor. Analysis of single-channel currents.Mol Pharmacol. 1984 Sep;26(2):304-13. Mol Pharmacol. 1984. PMID: 6090885
-
Functional regulation of nicotinic acetylcholine receptor channels in muscle.Ion Channels. 1992;3:177-206. doi: 10.1007/978-1-4615-3328-3_7. Ion Channels. 1992. PMID: 1384758 Review. No abstract available.
-
Making mouse muscle move.Trends Neurosci. 1990 Feb;13(2):39-41. doi: 10.1016/0166-2236(90)90063-g. Trends Neurosci. 1990. PMID: 1690926 Review. No abstract available.
Cited by
-
Activation of heteroliganded mouse muscle nicotinic receptors.J Physiol. 2005 Apr 15;564(Pt 2):359-76. doi: 10.1113/jphysiol.2004.078535. Epub 2005 Feb 17. J Physiol. 2005. PMID: 15718267 Free PMC article.
-
Current and future standards in treatment of myasthenia gravis.Neurotherapeutics. 2008 Oct;5(4):535-41. doi: 10.1016/j.nurt.2008.08.011. Neurotherapeutics. 2008. PMID: 19019304 Free PMC article. Review.
-
Progress in the treatment of myasthenia gravis.Ther Adv Neurol Disord. 2008 Sep;1(2):36-51. doi: 10.1177/1756285608093888. Ther Adv Neurol Disord. 2008. PMID: 21180568 Free PMC article.
-
Myasthenia gravis AChR antibodies inhibit function of rapsyn-clustered AChRs.J Neurol Neurosurg Psychiatry. 2020 May;91(5):526-532. doi: 10.1136/jnnp-2019-322640. Epub 2020 Mar 12. J Neurol Neurosurg Psychiatry. 2020. PMID: 32165373 Free PMC article.
-
Longitudinal Improvement in Respiratory Function Following Plasma Exchange in Patients with Severe Myasthenia Gravis.Neurocrit Care. 2025 Apr 3. doi: 10.1007/s12028-025-02238-9. Online ahead of print. Neurocrit Care. 2025. PMID: 40180670
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources